Neurobiological aspects of depressive disorder and antidepressant treatment: Role of glia

Physiological Research

Volumn 57, Issue 2, 2008, Pages 151-164

  Pav M ^a   Kovaru H ^a   Fiserova A ^b   Havrdova E ^a   Lisa V ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^c INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Antidepressant; Astrocyte; C6 glioma cells; Cell signal transduction; G proteins; Guanine binding proteins; Hippocampus; Immune system; Major depression; Mood disorder; Natural killer cells; Neurogenesis; Stress

Indexed keywords

ANTIDEPRESSANT AGENT;

ADAPTIVE BEHAVIOR; ANIMAL; DEPRESSION; DRUG EFFECT; GLIA; HUMAN; MENTAL STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; SHORT SURVEY; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ADAPTATION, PSYCHOLOGICAL; ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; NEUROGLIA; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; SYNAPTIC TRANSMISSION;

EID: 45849086975     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (117)

1. ABERG MA, ABERG ND, HEDBACKER H, OSCARSSON J, ERIKSSON PS: Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. J Neurosci 20: 2896-2903, 2000.
2. ALFONSO J, POLLEVICK GD, VAN DER HART MG, FLUEGGE G, FUCHS E, FRASCH AC: Identification of genes regulated by chronic psychosocial stress and antidepressant treatment in the hippocampus. Eur J Neurosci 19: 659-666, 2004.
3. 35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein. J Pharmacol Exp Ther 298: 116-121, 2001.
4. ARAQUE A, PARPURA V, SANZGIRI RP, HAYDON PG: Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 22: 208-215, 1999.
5. AROLT V, PETERS M, ERFURTH A, WIESMANN M, MISSER U, RUDOLF S, KIRCHNER H, ROTHERMUNDT M: S100B and response to treatment in major depression: a pilot study. Eur Neuropsychopharmacol 13: 235-239, 2003.
6. AVISSAR S, SCHREIBER G: Toward molecular diagnostics of mood disorders in psychiatry. Trends Mol Med 8: 294-300, 2002.
7. AVISSAR S, SCHREIBER G: The involvement of G proteins and regulators of receptor-G protein coupling in pathophysiology, diagnosis and treatment of mood disorders. Clin Chim Acta 336: 37-47, 2006.
8. BAL N, FIGUERAS G, VILARO MT, SUNOL C, ARTIGAS F: Antidepressant drugs inhibit a glial 5-hydroxytryptamine transporter in rat brain. Eur J Neurosci. 9: 1728-1738, 1997.
9. BARNES NM, SHARP T: A rewiew of central 5-HT receptors and their function. Neuropharmacology 38: 1083-1152, 1999.
10. BENMANSOUR S, OWENS WA, CECCHI M, MORILAK DA, FRAZER A: Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J Neurosci 22: 6766-6772, 2002.
11. BOWLEY MP, DREVETS WC, ÖNGÜR D, PRICE JL: Low glial numbers in the amygdala in major depressive disorder. Biol Psych 52: 404-412, 2002.
12. BROWN DR: Neurons depend on astrocytes in a coculture system for protection from glutamate toxicity. Mol Cell Neurosci. 13: 379-389, 1999.
13. BROWN ES, RUSH AJ, MCEWEN BS: Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacology 21: 474-484, 1999.
14. COTRINA ML, LIN JH, LOPEZ-GARCIA JC, NAUS M, NEDERGAARD M: ATP-mediated glia signaling. J Neurosci 20: 2835-2844, 2000.
15. COVIC T, TYSON G, SPENCER D, HOWE G: Depression in rheumatoid arthritis patients: demographic, clinical and psychological predictors. J Psychosom Res 60: 469-476, 2006.
16. CHEN J, RASENICK M: Chronic treatment of C6 glioma cells with antidepressant drugs increases functional coupling between a G protein (Gs) and adenylyl cyclase.J Neurochem 64, 724-732, 1995.
17. CZECH B, WELT T, FISCHER AK, ERHARDT A, SCHMITT W, MULLER MB, TOSCHI N, FUCHS E, KECK ME: Chronic psychosocial stress and concomitant repetitive transcranial magnetic stimulation: effects on stress hormone levels and adult hippocampal neurogenesis. Biol Psychiatry 52: 1047-1056, 2002.
18. DANBOLT NC: Glutamate uptake. Prog Neurobiol 65: 1-105, 2001.
19. 2 adrenoreceptors receptors and multiple sclerosis. Neurobiol. Dis 15: 331-339, 2004.
20. DESCHEPPER CF: Peptide receptors on astrocytes. Front Neuroendocrinol 19: 20-46, 1998.
21. 1 cytokine interferon-γ, independent of monoamine transporter blockade. Eur Neuropsychopharmacol 16: 481-490, 2006.
22. DOETSCH F, HEN R: Young and excitable: the function of new neurons in the adult mammalian brain. Curr Opin Neurobiol 15: 121-128, 2005.
23. DONATI RJ, RASENICK MM: Chronic antidepressant treatment prevents accumulation of gsalpha in cholesterol-rich, cytoskeletal-associated, plasma membrane domains (lipid rafts). Neuropsychopharmacology 30: 1238-1245, 2005.
24. DONATO R: S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33: 637-668, 2001.
25. DUMAN RS: Depression: a case of neuronal life and death? Biol Psychiatry 56: 140-145, 2004.
26. DUMAN RS, MONTEGGIA LM: A neurotrophic model for the stress-related mood disorders. Biol Psychiatry 59: 1116-1127, 2006.
27. DRUKARCH B, SCHEPENS E, STOOF JC, LANGEVELD CH, VAN MUISWINKEL FL: Astrocyte-enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen species. Free Radic Biol Med 25: 217-220, 1998.
28. FATEMI SH, LAURENCE JA, ARAGHI-NIKNAM M, STARY JM, SCHULZ SC, LEE S, GOTTESMAN II: Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression, but not schizophrenia. Schizophr Res 69: 317-323, 2004.
29. FIŠEROVÁ A, KOVÁŘŮ H, HAJDUOVA Z, MAREŠ V, STAREC M, KŘEN V, FLIEGER M, POSPÍŠIL M: Neuroimmunomodulation of natural killer (NK) cells by alkaloid derivates. Physiol Res 46: 119-125, 1997.
30. 2-dopamine and alpha-adrenoceptor antagonists in stress induced changes on immune responsiveness of mice. J Neuroimmunol 130: 55-65, 2002.
31. FULLER RW, WONG DT: Serotonin uptake and serotonin uptake inhibition. Ann N Y Acad Sci 600: 68-78, 1990.
32. GONZALES-MAESO J, RODRIGUES-PUERTAS R, MEANA JJ, GARCIA-SEVILLA JA, GUIMON J: Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders. Mol Psychiatry 7: 755-767, 2002.
33. GOULD TD, MANJI HK: Signaling networks in the pathophysiology and treatment of mood disorders. J Psychosom Res 53: 687-697, 2002.
34. GUBBA EM, FAWCETT JW, HERBERT J: The effects of corticosterone and dehydroepiandrosterone on neurotrophic factor mRNA expression in primary hippocampal and astrocyte cultures. Brain Res Mol Brain Res 127: 48-59, 2004.
35. GUILLEMIN GJ, KERR SJ, SMYTHE GA, SMITH DG, KAPOOR V, ARMATI PJ, CROITORU J, BREW BJ: The kynurenine pathway metabolism in human astrocytes: paradox for neuroprotection. J Neurochem 78: 842-853, 2001.
36. GUILLEMIN GJ, SMYTHE G, TAKIKAWA O, BREW BJ: Expression of indoleamine 2,3- dioxygenase and production of quinolinic acid by human microglia, astrocytes and neurons. Glia 49: 15-23, 2005.
37. HADDAD JJ, SAADE NE, SAFIEH-GARABEDIAN B: Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary- adrenal revolving axis. J Neuroimmunol 133: 119, 2002.
38. HAGG T: Molecular regulation of adult CNS neurogenesis: an integrated review. Trends Neurosci 28: 589-595, 2005.
39. HANSSON E, SIMONSSON P, ALLING C: Interactions between cyclic AMP and inositol phosphate transduction systems in astrocytes in primary culture. Neuropharmacology 29: 591-598, 1990.
40. HAUWEL M, FURON E, CANOVA C, GRIFFITHS M, NEAL J, GASQUE P: Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, "protective" glial stem cells and stromal ependymal cells. Brain Res Brain Res Rev 48: 220-233, 2005.
41. HAVRDOVA E: Aggressive multiple sclerosis - is there a role for stem cell transplantation? J Neurol 252 (Suppl 3): iii34-iii37, 2005.
42. HAYLEY S, POULTER MO, MERALI Z, ANISMAN H: The pathogenesis of clinical depression: stressor and cytokine induced alterations of cytoplasticity. Neuroscience 135: 659-678, 2005.
43. HERTZ L, ZIELKE HR: Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends Neurosci 27: 735-743, 2004.
44. HISAOKA K, NISHIDA A, KODA T, MIYATA M, ZENSHO H, MORINOBU S, OHTA M, YAMAWAKI S: Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells. J Neurochem 79: 25-34, 2001.
45. HISAOKA K, NISHIDA A, TAKEBAYASHI M, KODA T, YAMAWAKI S, NAKATA Y.: Serotonin increases glial cell line-derived neurotrophic factor release in rat C6 glioblastoma cells. Brain Res 1002: 167-170, 2004.
46. HORNER HC, PACKAN DR, SAPOLSKY RM: Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. Neuroendocrinology 52: 57-64, 1990.
47. HÖSLI E, HÖSLI L: Receptors for neurotransmitters on astrocytes in the mammalian central nervous system. Prog Neurobiol 40: 477-506, 1993.
48. HUGHES EG, MAGUIRE JL, MCMINN MT, SCHOLZ RE, SUTHERLAND ML: Loss of glial fibrillary acidic protein results in decreased glutamate transport and inhibition of PKA-induced EAAT2 cell surface trafficking. Brain Res Mol Brain Res 124: 114-123, 2004.
49. INAZU M, TAKEDA H, IKOSHI H, SUGISAWA M, UCHIDA Y, MATSUMIYA T: Pharmacological characterization and visualization of the glial serotonin transporter. Neurochem Int 39: 39-49, 2001.
50. INAZU M, TAKEDA H, MATSUMIYA T: Functional expression of the norepinephrine transporter in cultured rat astrocytes. J Neurochem 84: 136-144, 2003.
51. INOUE S, SUSUKIDA M, IKEDA K, MURASE K, HAYASHI K: Dopaminergic transmitter up-regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) synthesis in mouse astrocytes in culture. Biochem Biophys Res Commun 238: 468-472, 1997.
52. JACOBS BL, PRAAG H, GAGE FH: Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry 5: 262-269, 2000.
53. JUNKER V, BECKER A, HUHNE R, ZEMBATOV M, RAVATI A, CULMSEE C, KRIEGLSTEIN J: Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection. Eur J Pharmacol 446: 25-36, 2002.
54. KELLEY KW, BLUTHE RM, DANTZER R, ZHOU JH, SHEN WH, JOHNSON RW, BROUSSARD SR: Cytokine-induced sickness behavior. Brain Behav Immun 17 (Suppl 1): S112-S118, 2003.
55. KEMPERMANN G, KRONENBERG G: Depressed new neurons- adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression. Biol Psychiatry 54: 499-503, 2003.
56. KEMPERMANN G, WISKOTT L, GAGE FH: Functional significance of adult neurogenesis. Curr Opin Neurobiol 14: 186-191, 2004.
57. KOVÁŘŮ H, KOVÁŘŮ F: Basis of neuroimmunomodulation. (in Czech) In: Základy neuroimmunomodulace. H KOVÁŘŮ, F KOVÁŘŮ (eds), Galén, Prague, 2005, pp 203-208.
58. KOVÁŘŮ H, FIŠEROVÁ A, LISÁ V, ŠPANOVÁ A, KOVÁŘŮ F, VELEK J: Fluoxetine induced changes in C6 glioma cells and NK lymphocytes. In: Biologické základy psychických poruch. J SIKORA, Z FIŠAR et al. (eds), Galén Publ. Co, Prague, 1997, pp 108-112.
59. KOVÁŘŮ H, FIŠEROVÁ A, ŠPANOVÁ A, LISÁ V, FIŠAR Z, VELEK J: Antidepressants as neuroimmunomodulators at postreceptor level. J Neuroimmunol 90: 41, 1998.
60. KOVÁŘŮ; H, LISÁ V, FIŠAR Z, MALBOHAN I: Comparative analyses of antidepressant induced changes in G alpha subunit profiles. NeuroImmunomodulation 6: 460, 1999.
61. KOVÁŘŮ H, FIŠEROVÁ A, KOVÁŘŮ F, PACLT I, LISÁ V: Antidepressant or immunomodulator induced regulation of cell signalling in brain and immune system. Eur Neuropsychopharmacol 10 (Suppl 3): S269- S270, 2000.
62. KOVÁŘŮ H, FIŠEROVÁ A, KOVÁŘŮ F, POSPÍŠIL M, LISÁ V: Modulation of heterotrimeric GTP-binding proteins in immune system and brain. Czech J Anim Sci 46: 62-67, 2001.
63. KUBOTA N, KIUCHI Y, NEMOTO M, OYAMADA H, OHNO M, FUNAHASHI H, SHIODA S, OGUCHI K: Regulation of serotonin transporter gene expression in human glial cells by growth factors. Eur J Pharmacol 417: 69-76, 2001.
64. LAMING PR, KIMELBERG H, ROBINSON S, SALM A, HAWRYLAK N, MULLER C, ROOTS B, NG K: Neuronal-glial interactions and behaviour. Neurosci Biobehav Rev 24: 295-340, 2000.
65. LEE HJ, CHA JH, HAM BJ, HAN CS, KIM YK, LEE SH, RYU SH, KANG RH, CHOI MJ, LEE MS: Association between a G-protein beta3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders. Pharmacogenomics J 4: 29-33, 2004.
66. LEONARD BE: Inflammation and depression: is there a causal connection with dementia? (in Czech) Psychiatrie 10: 172-178, 2006.
67. LUCASSEN PJ, HEINE VM, MULLER MB, VAN DER BEEK VM, WIEGANT VM, DE KLOET ER, JOELS M, FUCHS E, SWAAB DF, CZEH B: Stress, depression an hippocampal apoptosis. CNS Neurol Disord Drug Targets 5: 531-546, 2006.
68. MANEV R, UZ T, MANEV H: Fluoxetine increases the content of neurotrophic protein S100β in the rat hippocampus. Eur J Pharmacol 420: R1-R2, 2001.
69. MAREŠ V, GIORDANO PA, PELLICCIARI C, SCHERINI E, LISÁ V, BOTTONE G, BOTTIROLI G: Changes in cell cycle and chromatin distribution in C6 glioma cells treated by dibutyryl cyclic AMP. Cell Prolif 24: 569-577, 1991.
70. MCEWEN BS, MAGARINOS AM, REAGAN LP: Structural plasticity and tianeptine: cellular and molecular targets. Eur Psychiatry 17: 318-330, 2002.
71. MERCIER G, LENNON AM, RENOUF B, DESSOROUX A, RAMAUGE M, COURTIN F, PIERRE M: MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. J Mol Neurosci 24: 207-216, 2004.
72. MIGUEL-HIDALGO JJ, RAJKOWSKA G: Comparison of prefrontal cell pathology between depression and alcohol dependence. J Psychiatr Res 37: 411-420, 2003.
73. MIYAZAKI I, ASANUMA M, DIAZ-CORRALES FJ, MIYOSHI K, OGAWA N: Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia. Brain Res 1029: 120-123, 2004.
74. MIZUTA I, OHTA M, OHTA K, NISHIMURA M, MIZUTA E, HAYASHI K, KUNO S: Selegiline and desmethylselegiline stimulate NGF, BDNF, and GDNF synthesis in cultured mouse astrocytes. Biochem Biophys Res Commun 279: 751-755, 2000.
75. MOJCA-JURIC DM, MIKLIC S, CARMAN-KRZAN M: Monoaminergic neuronal activity up-regulates BDNF synthesis cultured neonatal rat astrocytes. Brain Res 1108: 54-62, 2006.
76. MÜLLER HV, JUNGHANS U, KAPPLER J: Astroglial neurotrophic and neurite-promoting factors. Pharmacol Ther 65: 1-18, 1995.
77. NAKAGAWA T, SCHWARTZ JP: Expression of neurotrophic factors and cytokines and their receptors on astrocytes in vivo. Adv Cell Mol Biol 31: 561-574, 2004.
78. NAKYAMA T, SOMOGI-SOGA T, INOUE N. Astrocyte-derived factors instruct differentiation of embryonic stem cells into neurons. Neurosci Res 46: 241-249, 2003.
79. NESTLER EJ, BARROT M, DILEONE RJ, EISCH AJ, GOLD SJ, MONTEGGIA LM: Neurobiology of depression. Neuron 34: 13-25, 2002.
80. NEUMEISTER A: Tryptophan depletion, serotonin and depression: where do we stand? Psychopharmacol Bull 37: 99-115, 2003.
81. NICHOLS NR, AGOLLEY D, ZIEBA M, BYE N: Glucocorticoid regulation glial responses during hippocampal neurodegeneration and regeneration. Brain Res Brain Res Rev 48: 287-301, 2005.
82. NOWAK G, TRULLAS R, LAYER RT, SKOLNICK P, PAUL IA: Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. J Pharmacol Exp Ther 265: 1380-1386, 1993.
83. OHTA K, KUNO S, MIZUTA I, FUJINAMI A, MATSUI H, OHTA M: Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes. Life Sci 73: 617-626, 2003.
84. O'KUSKY J, COLONNIER M: A laminar analysis of the number of neurons, glia, and synapses in the adult cortex (area 17) of adult macaque monkeys. J Comp Neurol 210: 278-290, 1982.
85. ÖNGÜR D, DREVETS WC, PRICE JL: Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U.S.A. 95: 13290-13295, 1998.
86. PACHECO MA, STOCKMEIER C, MELTZER HY, OVERHOLSER JC, DILLEY GE, JOPE RS. Alterations in phosphoinositide signalling and G-protein levels in depressed suicide brain. Brain Res 723: 37-45, 1996.
87. PARPURA V, HAYDON PG: Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons. Proc Natl Acad Sci USA 97: 8629-8634, 2000.
88. PAWLAK J, BRITO V, KUcombining double acute accentPPERS E, BEYER C: Regulation of glutamate transporter GLAST and GLT-1 expression in astrocytes by estrogen. Brain Res Mol Brain Res 138: 1-7, 2005.
89. PORTER JT, MCCARTHY KD: Atrocytic neurotransmitter receptors in situ and in vivo. Prog Neurobiol 51: 439-455, 1997.
90. RAJKOWSKA G: Depression: what we can learn from postmortem studies. Neuroscientist 9: 273-284, 2003.
91. REYNAERT C, JANNE P, BOSLY A, STAQUET P, ZDANOWICZ N, VAUSE M, CHATELAIN B, LEJEUNE D: From health locus of control to immune control: internal locus of control has a buffering effect on natural killer cell activity decrease in major depression. Acta Psychiat Scand 92: 294-300, 1995.
92. RIDET JL, MALHOTRA SK, PRIVAT A, GAGE FH: Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 20: 570-577, 1997.
93. SAPENA R, MORIN D, ZINI R, MORIN C, TILLEMENT JP: Desipramine treatment differently down-regulates beta-adrenoceptors of freshly isolated neurons and astrocytes. Eur J Pharmacol 300: 159-162, 1996.
94. SCHILDKRAUT JJ, MOONEY JJ: Toward a rapidly acting antidepressant: the normetanephrine and extraneuronal monoamine transporter (uptake 2) hypothesis. Am J Psychiatry 161: 909-911, 2004.
95. SEKOT M, GURLICH R, MARUNA P, PÁV M, UHLÍKOVÁ P: Evaulation of anxiety and depression of patients with malignant gastrointestinal cancer. (in Czech) Čes Slov Psychiatrie 5: 252-257, 2005.
96. SERI B, GARCIA-VERDUNO JM, MCEWEN BS, ALVAREZ-BUYLLA A: Astrocytes give rise to new neurons in the adult mammalian hippocampus. J Neurosci 21: 7153-7160, 2001.
97. SHARMA G, VIJAYARAGHAVAN S: Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores. Proc Natl Acad Sci USA 98: 3631-3632, 2001.
98. SHELINE ZI: Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry 54: 338-352, 2003.
99. SHELINE ZI, MITTLER BL, MINTUN MA: The hippocampus and depression. Eur Psychiatry 17: 300-305, 2002.
100. SCHIEPERS OJ, WICHERS MC, MAES M: Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29: 637-638, 2005.
101. SLEZAK M, PFRIEGER FW: New roles for astrocytes: regulation of CNS synaptogenesis. Trends Neurosci 26: 531-535, 2003.
102. SOFRONIEW MW: Reactive astrocytes in neuronal repair and protection. Neuroscientist 11: 400-407, 2005.
103. SPIEGEL AM: Defects in G protein coupled signal transduction in human disease. Annu Rev Physiol 58: 143-170, 1996.
104. STEFFENS DC, BYRUM CHE, MCQUOID DR, GREENBERG DL, PAYNE ME, BLITCHINGTON TF, MACFALL JR, KRISHNAN KRR: Hippocampal volume in geriatric depression. Biol Psychiatry 48: 301-309, 2000.
105. STONE EA, ARIANO MA: Are glial cells targets of the central noradrenergic system: a review of the evidence. Brain Res Brain Res Rev 14: 297-309, 1989.
106. 2+ channel regulation in mouse embryonic stem cell-derived neurons. Eur J Neurosci 9: 824-832, 1997.
107. SYKOVÁ E: Glia and volume transmission during physiological and pathological states. J Neural Transm 112: 137-147, 2005.
108. ŠPANOVÁ A, KOVÁŘŮ H, LISÁ V, LUKÁŠOVÁ E, RITTICH B: Estimation of apoptosis in C6 glioma cells treated with antidepressants. Physiol Res 46: 161-164, 1997.
109. TACUMA K, BABA A, MATSUDA T: Astrocytic apoptosis: implications for neuroprotection. Prog Neurobiol 72: 111-127, 2004.
110. TAFET GE, BERNARDINI R: Psychoneuroendocrinological links between chronic stress and depression. Prog Neuropsychopharmacol Biol Psychiatry 27: 893- 903, 2003.
111. VEREKER E, O'DONNELL E, LYNCH A, KELLY A, NOLAN Y, LYNCH MA: Evidence that interleukin-1β and reactive oxygen species production play a pivotal role in stress induced impairment of LTP in the rat dentate gyrus. Eur J Neurosci 14: 1809-1819, 2001.
112. VERKHRATSKY A, STEINHÄUSER CH: Ion channels in glial cells. Brain Res Rev 32: 380-412, 2000.
113. VILLOSLADA P, GENAIN P: Role of nerve growth factor and other trophic factors in brain inflammation. Prog Brain Res 146: 403-414, 2004.
114. VITHINGHAM M, HEIM C, NEWPORT J, MILLER AH, ANDERSON E, BRONEN R, BRUMMER M, STAIB L, VERMETTEN E, CHARNEY DS, NEMEROFF CB, BREMNER JD: Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatr 159: 2072-2080, 2002.
115. 1a receptors: evidence for a glial mechanism. Brain Res 782: 235-239, 1998.
116. YOUNG LT, LI PP, KISH SJ, SIU KP, KAMBLE A, HORNYKIEWICZ O, WARSH JJ: Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. J Neurochem 61: 890-898, 1993.
117. ZELENAIA O, SCHLAG D, GOCHENAUER O, GANEL R, SONG W, BEELSEY JS, GRINSPAN JB, ROTHSTEIN JD, ROBINSON MB: Epidermal growth factor receptor agonists increase expression of glutamate transporter GLT-1 in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor NFkB. Mol Pharmacol 57: 667-678, 2000.